TELSOVA

Serial Number 77796722
606

Registration Progress

Application Filed
Aug 4, 2009
Under Examination
Mar 30, 2010
Approved for Publication
Jan 5, 2010
Published for Opposition
Jan 5, 2010
Registered

Trademark Image

TELSOVA

Basic Information

Serial Number
77796722
Filing Date
August 4, 2009
Published for Opposition
January 5, 2010
Abandonment Date
November 1, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 1, 2010
Classes
005

Rights Holder

AstraZeneca AB

99
Address
Västra Mälarehamnen 9
Sodertalje 151-85
SE

Ownership History

AstraZeneca AB

Original Applicant
99
Sodertalje SE

AstraZeneca AB

Owner at Publication
99
Sodertalje SE

Legal Representation

Attorney
Travis P. Boozer

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Nov 1, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 1, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 30, 2010 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 5, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 5, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 30, 2009 ALIE A ASSIGNED TO LIE Loading...
Nov 30, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 12, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 5, 2009 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 5, 2009 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 5, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 2, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 7, 2009 NWAP I NEW APPLICATION ENTERED Loading...
Aug 7, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the metabolism, respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology, and diabetes
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "TELSOVA" has no meaning in a foreign language.

Classification

International Classes
005